NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
171 hedge funds and large institutions have $1.59B invested in NxStage Medical Inc. in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 59 reducing their positions, and 24 closing their positions.
17% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 24
12% more capital invested
Capital invested by funds: $1.42B → $1.59B (+$168M)
2% more funds holding
Funds holding: 168 → 171 (+3)
4% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $1.99M
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
19% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 59
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAL
TIG Advisors LLC
New York
|
+$47.9M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$14.1M |
| 3 |
BlackRock
New York
|
+$13.5M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$13.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pennant Capital Management
Summit,
New Jersey
|
-$37.4M |
| 2 |
JP Morgan Chase
New York
|
-$18.3M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$10.9M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$10.7M |
| 5 |
Goldman Sachs
New York
|
-$8.57M |
NXTM Hedge Fund Activity: Q2 2018 in Review
171 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q2 2018, worth a combined $1.59B — up 12% from $1.42B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new NXTM positions and 24 closed out — a net gain of 4 holders — while 48 added to existing stakes and 59 trimmed.
The largest buyer was TIG Advisors LLC, adding an estimated $47.9M. The largest seller was Pennant Capital Management, cutting an estimated $37.4M.
- 171 institutional investors held NxStage Medical Inc. (NXTM) as of Q2 2018, up from 168 in Q1 2018.
- Funds reported $1.59B of NxStage Medical Inc. stock for Q2 2018, up 12% quarter-over-quarter.
- 28 funds opened new NxStage Medical Inc. positions in Q2 2018 and 24 closed out, a net change of +4 holders.
- The largest NxStage Medical Inc. buyer in Q2 2018 was TIG Advisors LLC, an estimated $47.9M added.
- The largest NxStage Medical Inc. seller in Q2 2018 was Pennant Capital Management, an estimated $37.4M sold.
Based on aggregated 13F filings for Q2 2018.